NASDAQ:CYAN - Cyanotech Stock Price, News & Analysis

$2.42
+0.02 (+0.83 %)
(As of 09/19/2019 02:56 AM ET)
Today's Range
$2.42
Now: $2.42
$2.50
50-Day Range
$2.36
MA: $2.49
$2.70
52-Week Range
$2.01
Now: $2.42
$4.07
Volume1,600 shs
Average Volume3,552 shs
Market Capitalization$14.25 million
P/E RatioN/A
Dividend YieldN/A
Beta0.84
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, as well as directly to consumers; and in bulk quantities to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CYAN
CUSIPN/A
Phone808-326-1353

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$30.20 million
Book Value$2.55 per share

Profitability

Net Income$-3,600,000.00

Miscellaneous

Employees118
Market Cap$14.25 million
Next Earnings Date11/11/2019 (Estimated)
OptionableNot Optionable

Receive CYAN News and Ratings via Email

Sign-up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter.


Cyanotech (NASDAQ:CYAN) Frequently Asked Questions

What is Cyanotech's stock symbol?

Cyanotech trades on the NASDAQ under the ticker symbol "CYAN."

How were Cyanotech's earnings last quarter?

Cyanotech Corp (NASDAQ:CYAN) issued its quarterly earnings results on Tuesday, August, 13th. The biotechnology company reported ($0.02) EPS for the quarter. The biotechnology company earned $8.07 million during the quarter. Cyanotech had a negative return on equity of 15.79% and a negative net margin of 7.88%. View Cyanotech's Earnings History.

When is Cyanotech's next earnings date?

Cyanotech is scheduled to release their next quarterly earnings announcement on Monday, November 11th 2019. View Earnings Estimates for Cyanotech.

Has Cyanotech been receiving favorable news coverage?

Headlines about CYAN stock have been trending negative recently, according to InfoTrie. The research group rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cyanotech earned a news impact score of -2.9 on InfoTrie's scale. They also gave media stories about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Cyanotech.

Are investors shorting Cyanotech?

Cyanotech saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 800 shares, an increase of 700.0% from the July 31st total of 100 shares. Based on an average daily volume of 2,200 shares, the short-interest ratio is currently 0.4 days. Currently, 0.0% of the shares of the stock are short sold. View Cyanotech's Current Options Chain.

Who are some of Cyanotech's key competitors?

What other stocks do shareholders of Cyanotech own?

Who are Cyanotech's key executives?

Cyanotech's management team includes the folowing people:
  • Mr. Mawae R. Morton, Chief Exec. Officer (Age 52)
  • Dr. Gerald R. Cysewski Ph.D., Co-Founder, Pres & Vice Chairman (Age 70)
  • Mr. Brian Brett Orlopp, VP of Fin. & CFO and Sec.
  • Mr. Glenn D. Jensen, VP of Manufacturing & Infrastructure (Age 61)

Who are Cyanotech's major shareholders?

Cyanotech's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Wells Fargo & Company MN (6.37%) and Citadel Advisors LLC (0.27%). View Institutional Ownership Trends for Cyanotech.

Which institutional investors are selling Cyanotech stock?

CYAN stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN. View Insider Buying and Selling for Cyanotech.

Which institutional investors are buying Cyanotech stock?

CYAN stock was bought by a variety of institutional investors in the last quarter, including Citadel Advisors LLC. View Insider Buying and Selling for Cyanotech.

How do I buy shares of Cyanotech?

Shares of CYAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cyanotech's stock price today?

One share of CYAN stock can currently be purchased for approximately $2.42.

How big of a company is Cyanotech?

Cyanotech has a market capitalization of $14.25 million and generates $30.20 million in revenue each year. Cyanotech employs 118 workers across the globe.View Additional Information About Cyanotech.

What is Cyanotech's official website?

The official website for Cyanotech is http://www.cyanotech.com/.

How can I contact Cyanotech?

Cyanotech's mailing address is 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA KONA HI, 96740. The biotechnology company can be reached via phone at 808-326-1353 or via email at [email protected]


MarketBeat Community Rating for Cyanotech (NASDAQ CYAN)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  106 (Vote Outperform)
Underperform Votes:  115 (Vote Underperform)
Total Votes:  221
MarketBeat's community ratings are surveys of what our community members think about Cyanotech and other stocks. Vote "Outperform" if you believe CYAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/19/2019 by MarketBeat.com Staff

Featured Article: Buyback

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel